Evidence map›Paper›PMID 40168402›Full record

ArticlePLoS pathogens2025

Single-Cell Transcriptomic Analysis of Kaposi Sarcoma.

Daniel A Rauch, Paula Valiño Ramos, Mariam Khanfar, John Harding, Ancy Joseph, Anam Fahad, Paul Simonson, Isabel Risch, Obi Griffith, Malachi Griffith and 1 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Spatial Profiling Shows That Lymphatic Endothelial Cells Form the Core of Kaposi Sarcoma (KS).Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026
    Article
  8. Article
  9. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Daniel A RauchDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Paula Valiño RamosDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Mariam KhanfarDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
John HardingDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Ancy JosephDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Anam FahadDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, United States of America.
Paul SimonsonDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, United States of America.
Isabel RischDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Obi GriffithDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Malachi GriffithDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Lee RatnerDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.ORCID 0000-0003-2744-7294

Funding

Consortium for Advancing Management and Prevention of Cancer in People with HIVUM1CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Joseph A. Sparano · 2015 to 2026
$253.7M
Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi SarcomaR21CA257493 · NCI · WASHINGTON UNIVERSITY · PI RATNER, LEE, RAUCH, DANIEL ARTHUR · 2021 to 2022
$433k
NCI NIH HHS P30 CA091842NCI NIH HHS R21 CA257493NCI NIH HHS UM1 CA121947
6 · The paper itself

Abstract

Kaposi Sarcoma (KS) is a complex tumor caused by KS-associated herpesvirus 8 (KSHV). Histological analysis reveals a mixture of "spindle cells", vascular-like spaces, extravasated erythrocytes, and immune cells. In order to elucidate the infected and uninfected cell types in KS tumors, we examined twenty-five skin and blood samples from sixteen subjects by single cell RNA sequence analyses. Two populations of KSHV-infected cells were identified, one of which represented a CD34-negative proliferative fraction of endothelial cells, and the second representing CD34-positive cells expressing endothelial genes found in a variety of cell types including high endothelial venules, fenestrated capillaries, and endothelial tip cells. Although both infected clusters contained cells expressing lytic and latent KSHV genes, the CD34+ cells expressed more K5 and less K12. Novel cellular biomarkers were identified in the KSHV infected cells, including the sodium channel SCN9A. The number of KSHV positive cells was found to be less than 10% of total tumor cells in all samples and correlated inversely with tumor-infiltrating immune cells. T-cell receptor clones were expanded in KS tumors and blood, although in differing magnitudes. Changes in cellular composition in KS tumors after treatment with antiretroviral therapy alone, or immunotherapy were noted. These studies demonstrate the feasibility of single cell analyses to identify prognostic and predictive biomarkers.

Indexed as

Herpesvirus 8, HumanSarcoma, KaposiSingle-Cell AnalysisTranscriptomeAgedEndothelial CellsFemaleGene Expression ProfilingHumansMaleMiddle Aged

Identifiers

PMID40168402
PMCPMC11984749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.